4//SEC Filing
Esperion Therapeutics, Inc. 4
Accession 0001179110-17-000121
$ESPRCIK 0001434868operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:42 PM ET
Size
5.4 KB
Accession
0001179110-17-000121
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-03+55,000→ 55,000 totalExercise: $12.88Exp: 2027-01-03→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 3, 2017.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434868
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:42 PM ET
- Size
- 5.4 KB